The pharmaceutical concern Astra Zeneca has suspended clinical trials of a vaccine against coronavirus, as one of the volunteers in the experiment developed health problems. According to the concern, independent experts are testing whether the patient's illness is associated with the serum injected. As noted by the European media, this precedent gives reason for joy rather than disappointment.
Science has the decisive word!
As the newspaper El Periodico de Catalunya notes, the fact of the suspension of clinical trials should be regarded positively:
вЂњThe willingness to interrupt clinical trials until the last doubts have been dispelled, as well as the obligation of pharma companies not to request a license for drugs until they meet the strictest medical and ethical standards, is a kind of safety guarantee. Therefore, there is no need to experience special fears when the vaccine, under certain conditions, will be ready for use. At the same time, those supposedly already available drugs do not inspire confidence, during the development of which political pressure was a much more powerful argument than strictly scientific criteria вЂ” as was the case in Russia, China, and the United States.вЂќ
There is no reason for euphoria yet
Now in many countries of the world, the development of a vaccine against coronavirus is in full swing, but so far there has been no progress, says Corriere del Ticino:
вЂњIn recent weeks, the feverish work in scientific laboratories has become very closely intertwined with issues of geopolitics. Several world powers have already announced that they are on the verge of developing a miracle formula вЂ” or even found one. But then they backed down and continued to work with pharmaceutical laboratories in the hope of being the first to finish. The reality is that today we can at best talk about "virtual vaccines" since no one country can present a clear medical solution to the issue.вЂќ